Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its price objective boosted by research analysts at Craig Hallum from $14.00 to $16.00 in a research note issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price target indicates a potential upside of 45.19% from the stock’s previous […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective boosted by Needham & Company LLC from $13.00 to $13.50 in a report issued on Thursday, Marketbeat reports. Needham & Company LLC currently has a buy rating on the stock. CLBT has been the topic of several other reports. Bank of America upgraded Cellebrite DI […]
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) traded down 4.6% during trading on Wednesday . The stock traded as low as $11.29 and last traded at $11.32. 242,236 shares were traded during trading, a decline of 74% from the average session volume of 936,235 shares. The stock had previously closed at $11.87. […]
ARK Investment Management LLC trimmed its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 11.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 260,711 shares of the company’s stock after selling 33,020 shares during the period. ARK Investment Management LLC owned […]
ARK Investment Management LLC lowered its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 11.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 260,711 shares of the company’s stock after selling 33,020 shares during the quarter. ARK Investment Management LLC’s holdings in Cellebrite DI were worth $2,258,000 as of […]